Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINCOMYCIN vs LISDEXAMFETAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINCOMYCIN vs LISDEXAMFETAMINE: Safety Overview

Metric LINCOMYCIN LISDEXAMFETAMINE
Total FAERS Reports 210 851
Deaths Reported 21 153
Death Rate 10.0% 18.0%
Hospitalizations 37 214
Average Patient Age 46.3 yrs 29.7 yrs
% Female Patients 69.3% 56.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Pharmacia & Upjohn Company LLC N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A